Back to 
BlackRock, Inc.
BlackRock, Inc.
RARE7 quarters
Position history for BlackRock, Inc.'s holdings in ULTRAGENYX PHARMACEUTICAL IN
BlackRock, Inc. holds 10.7M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $355.7M as of 2026-Q2. The position was increased (+46.0% shares). RARE represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$355.7M
Current Shares
10.7M
Total Value Change
+$80.8M
Total Shares Change
+4.1M
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors